Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MAPKs as modifiers of the rac, axin, and beta-catenin pathways and methods of use

MAPKs as modifiers of the rac, axin, and beta-catenin pathways and methods of use

US Patent 8067180 · Granted Nov 29, 2011

Estimated economic value: $3,190,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating PR-positive, luminal A breast cancer with PI3K inhibitor, pi2018
PIK4CA as modifier of the Rac pathway and methods of use2013
PIK4CA as modifier of the Rac pathway and methods of use2013
Marks as modifers of the PTEN pathway and methods of use2012
Marks as modifers of the PTEN pathway and methods of use2012
MELKS as modifiers of the Rac pathway and methods of use2011
MELKS as modifiers of the Rac pathway and methods of use2011
MELKS as modifiers of the Rac pathway and methods of use2011
TAOJIKs as modifiers of the beta-catenin pathway and methods of use2011
TAOJIKs as modifiers of the beta-catenin pathway and methods of use2011
HPRP4s modifiers of the p53 pathway and methods of use2011
Presenilin enhancers assays2006